B
attling pathogens and shaping neuronal growth seem to have as much in common as accounting and skydiving. But both tasks involve one of the Toll-like proteins, as Ma et al. report on page 209. The study is the fi rst to discover a function for a member of the Toll-like family within neurons.
Toll-like receptors (TLRs) enable mammalian immune cells to identify interlopers. TLR8, for instance, recognizes RNA on the loose, a sign of viral infection or cell destruction. The Drosophila equivalents of the proteins, the Toll receptors, also supervise synapse formation and axon growth, researchers have discovered. Although previous studies had revealed that mammalian neurons manufacture TLRs, no one had shown that the molecules performed a job in these cells.
Ma et al. found that brain levels of TLR8 shot up in the early mouse embryo and fell after birth, suggesting that the molecule participates in nervous system development. To clarify its role, the researchers dosed embryonic brain cells with a compound that stimulates TLR8. The treatment impeded the growth of neurites, the branches that sprout from developing neurons, and spurred some of the cells to kill themselves. An antibody that latches onto TLR8 prevented both effects.
TLR8 usually raises the alarm by activating the signaling pathway headed by NF-κB. But Ma et al. showed that NF-κB remained off in neurons, indicating that the receptor acts in these cells through an unidentifi ed pathway. The researchers speculate that TLR8 might serve as a danger detector in neurons. If it senses infection or tissue damage, it may deter neurons from entering the trouble spot by pruning their neurites or triggering their suicide.
Without Endo180 to release their tails, cells elongate instead of migrating.
Endosomes bring up the rear L ike jilted lovers, migrating cells need to let go before they can move on. Slithering cells get help from endosomes, via a receptor that spurs tails to detach from the surface, as Sturge et al.
show on page 337. Before it travels, a cell breaks down the focal adhesions that link it to a substrate or the adherens junctions that bind it to other cells. Activation of Rho kinase (ROCK) aids the process by enabling the cell to disengage its rear end, but what controls ROCK isn't certain. Sturge et al. investigated the possible role of endosomes, which get involved in a multitude of cell signaling events. They fi nd that an endosomelocalized receptor, called Endo180, triggers migration by breaking connections.
Internalized Endo180 is known to set off migration.
The authors found that, when cancer cells were depleted of Endo180, their front ends advanced, but their tails remained anchored, and they stretched like pieces of taffy. The loss of two other endosome receptors, however, did not interfere with crawling.
Endo180 also disrupted adherens junctions. Cranking up production of the protein cut the amount of E-cadherin at these contact points, destabilizing the connections between cells.
To determine whether Endo180 works by activating ROCK, the researchers measured phosphorylation of myosin light chain-2, which retracts the cell's tail. ROCK adds phosphate groups to the myosin, but the degree of phosphorylation plunged in the Endo180-depleted cells. Just how the receptor activates ROCK has not been worked out.
Endo180 cycles between endosomes and the cell surface, and the study's fi ndings suggest that it is the internal version that frees the tail. Endosomes sporting Endo180 accumulate in the rear of cells. And cells expressing a version of Endo180 that remains at the plasma membrane failed to detach. Extracellular collagen, Endo180's favorite ligand, was not necessary for deadhesion, but it is possible that collagen produced within motile cells might promote or limit its signaling capacity. 
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